InvestorsHub Logo
icon url

Gold Seeker

01/11/07 1:19 AM

#7791 RE: fluffy #7778

From the latest annual report. This is a statement by the new auditors and they don't think the SEC filings are accurate either.
*****************************************************
ITEM 8A. CONTROLS AND PROCEDURES



As of the end of the fiscal year ended December 31, 2005, the Company carried out an evaluation, under the supervision and with the participation of members of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our company's disclosure controls and procedures pursuant to Rule 13a-15(b) of the U.S. Securities Exchange Act of 1934 (the "Exchange Act"). Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2005, our disclosure controls and procedures, related to internal control over financial reporting and the recording of certain equity transactions, were not effective in light of the material weaknesses described below.

We were advised by Manning Elliott LLP, our independent auditors,

that during their performance of audit procedures related to our financial statements for the fiscal period ended December 31, 2005, they identified a "material weakness" in our internal controls as defined in Statement on Auditing Standards No. 60, "Communication of Internal Control Related Matters Noted in an Audit" ("SAS 60"). The material weakness is described below:



18
--------------------------------------------------------------------------------




Inadequate controls over equity transactions. We do not have adequate review and supervision controls or sufficient supporting documentation of certain equity-related transactions to ensure that equity transactions are properly valued and recorded on a timely basis. As a result, adjustments in the equity accounts and financial statements could occur. If we were not, or are not in future periods, successful in identifying these adjustments, our quarterly or annual financial statements could be materially misstated, which could require a restatement.


We are in the process of reviewing and strengthening our internal control procedures and intend to pursue actions to ensure all aspects of our controls related to the above described area. Such actions include but are not necessarily limited to the following:


Ÿ We will utilize an outside consulting firm to review all equity transactions and assist in the implementation of appropriate review and supervision controls to ensure the proper and timely recording of equity transactions.



Ÿ We will have extensive internal review and approval of all equity transactions and ensure proper supporting documentation is maintained.



Our disclosure controls and procedures are designed to ensure that the information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission's (the "SEC") rules and forms, and to reasonably assure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met under all potential conditions, regardless of how remote, and may not prevent or detect all error and all fraud. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been prevented or detected.


We continue to improve and refine our internal controls as an ongoing process. Other than as summarized above, there have been no changes in our internal controls over financial reporting or other factors that have materially affected, or are reasonably likely to materially affect, our internal controls.


The certifications of our principal executive officer and principal financial officer required in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 are attached as exhibits to this Annual Report on Form 10-KSB. The disclosures set forth in this Item 8A contain information concerning (i) the evaluation of our disclosure controls and procedures, and changes in internal control over financial reporting, referred to in paragraph 4 of the certifications, and (ii) material weaknesses in the design or operation of our internal control over financial reporting, referred to in paragraph 5 of the certifications. Those certifications should be read in conjunction with this Item 8A for a more complete understanding of the matters covered by the certifications.
icon url

Gold Seeker

01/11/07 1:21 AM

#7792 RE: fluffy #7778

The item below is from the latest annual report and has Wittenbergs common stock holdings at 3,332,278 as of March 15, 2006. That does not include the options listed in the next paragraph. On a form 4 dated April 12, 2006 it shows 1,204,425. Where are the missing 2,127,853 shares?
*******************************************************************************************

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.



The following table sets forth, as of March 15, 2005, information with respect to the shareholdings of (i) each person owning beneficially 5% or more of Biocurex’s common stock (ii) each officer and director of Biocurex (iii) all officers and directors as a group. Unless otherwise indicated, each owner has sole voting and investment powers over his shares of common stock.

Name and Address Number of
Shares (1) Percent of
Class

Dr. Ricardo Moro 1,805,000 5.09 %
1007-1625 West 13 th Avenue
Vancouver, British Columbia
Canada V6J 2E9

Dr. Gerald Wittenberg 3,332,278 9.39 %
6857 Churchill Street
Vancouver, British Columbia
Canada V6P 5B4

Dr. Phil Gold 105,000 0.30 %
3225 The Boulevard
Westmount, Quebec
Canada H3Y 1S4

All Officers and Directors 5,242,278 14.77 %
as a Group (3 persons)



27
--------------------------------------------------------------------------------




(1) Includes shares issuable upon the exercise of options granted to the following persons, all of which are presently exercisable.



Name Shares Issuable Upon
Exercise of Options Option Exercise
Price

Dr. Ricardo Moro 1,555,000 $ 0.001
Dr. Gerald Wittenberg 252,278 $ 0.05
Dr. Gerald Wittenberg 1,275,000 $ 0.08
Dr. Gerald Wittenberg 1,555,000 $ 0.001
Dr. Phil Gold 105,000 $ 0.001